210 related articles for article (PubMed ID: 11035676)
21. Comparison of budesonide/formoterol Turbuhaler with fluticasone/salmeterol Diskus for treatment effects on small airway impairment and airway inflammation in patients with asthma.
Hozawa S; Terada M; Hozawa M
Pulm Pharmacol Ther; 2011 Oct; 24(5):571-6. PubMed ID: 21624490
[TBL] [Abstract][Full Text] [Related]
22. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C
Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
[TBL] [Abstract][Full Text] [Related]
23. Subsensitivity to bronchoprotection against adenosine monophosphate challenge following regular once-daily formoterol.
Aziz I; Tan KS; Hall IP; Devlin MM; Lipworth BJ
Eur Respir J; 1998 Sep; 12(3):580-4. PubMed ID: 9762783
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing.
Kerwin EM; Oppenheimer JJ; LaForce C; Parasuraman B; Miller CJ; O'Dowd L; Goldman M
Ann Allergy Asthma Immunol; 2009 Jul; 103(1):62-72. PubMed ID: 19663129
[TBL] [Abstract][Full Text] [Related]
25. Budesonide/formoterol pressurized metered-dose inhaler versus budesonide: a randomized controlled trial in black patients with asthma.
Spector SL; Martin UJ; Uryniak T; O'Brien CD
J Asthma; 2012 Feb; 49(1):70-7. PubMed ID: 22133208
[TBL] [Abstract][Full Text] [Related]
26. Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone.
Zetterström O; Buhl R; Mellem H; Perpiñá M; Hedman J; O'Neill S; Ekström T
Eur Respir J; 2001 Aug; 18(2):262-8. PubMed ID: 11529282
[TBL] [Abstract][Full Text] [Related]
27. Difference in time-course of improvement in asthma control measures between budesonide and budesonide/formoterol.
Matsunaga K; Kawabata H; Hirano T; Sugiura H; Minakata Y; Ichinose M
Pulm Pharmacol Ther; 2013 Apr; 26(2):189-94. PubMed ID: 23123925
[TBL] [Abstract][Full Text] [Related]
28. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.
Wenzel S; Castro M; Corren J; Maspero J; Wang L; Zhang B; Pirozzi G; Sutherland ER; Evans RR; Joish VN; Eckert L; Graham NM; Stahl N; Yancopoulos GD; Louis-Tisserand M; Teper A
Lancet; 2016 Jul; 388(10039):31-44. PubMed ID: 27130691
[TBL] [Abstract][Full Text] [Related]
29. Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma.
Lalloo UG; Malolepszy J; Kozma D; Krofta K; Ankerst J; Johansen B; Thomson NC
Chest; 2003 May; 123(5):1480-7. PubMed ID: 12740264
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
[TBL] [Abstract][Full Text] [Related]
31. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
[TBL] [Abstract][Full Text] [Related]
32. Low-dose inhaled budesonide once or twice daily for 27 months in children with mild asthma.
Jónasson G; Carlsen KH; Jonasson C; Mowinckel P
Allergy; 2000 Aug; 55(8):740-8. PubMed ID: 10955700
[TBL] [Abstract][Full Text] [Related]
33. Assessment of Consistency of Fixed Airflow Obstruction Status during Budesonide/Formoterol Treatment and Its Effects on Treatment Outcomes in Patients with Asthma.
Tashkin DP; Moore GE; Trudo F; DePietro M; Chipps BE
J Allergy Clin Immunol Pract; 2016; 4(4):705-12. PubMed ID: 27039236
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory and functional effects of increasing asthma treatment with formoterol or double dose budesonide.
Menezes MB; Teixeira AL; Terra Filho J; Vianna EO
Respir Med; 2008 Oct; 102(10):1385-91. PubMed ID: 18632258
[TBL] [Abstract][Full Text] [Related]
35. Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide.
Miraglia del Giudice M; Piacentini GL; Capasso M; Capristo C; Maiello N; Boner AL; Capristo AF
Respir Med; 2007 Aug; 101(8):1809-13. PubMed ID: 17418554
[TBL] [Abstract][Full Text] [Related]
36. Budesonide/formoterol maintenance and reliever therapy in moderate-to-severe asthma: effects on eosinophilic airway inflammation.
Takeyama K; Kondo M; Tagaya E; Kirishi S; Ishii M; Ochiai K; Isono K; Tamaoki J
Allergy Asthma Proc; 2014; 35(2):141-7. PubMed ID: 24717791
[TBL] [Abstract][Full Text] [Related]
37. Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol.
Pavord ID; Jeffery PK; Qiu Y; Zhu J; Parker D; Carlsheimer A; Naya I; Barnes NC
J Allergy Clin Immunol; 2009 May; 123(5):1083-9, 1089.e1-7. PubMed ID: 19368965
[TBL] [Abstract][Full Text] [Related]
38. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
Akamatsu T; Shirai T; Kato M; Yasui H; Hashimoto D; Fujisawa T; Tsuchiya T; Inui N; Suda T; Chida K
Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566
[TBL] [Abstract][Full Text] [Related]
39. Dose-response comparison of budesonide dry powder inhalers using adenosine monophosphate bronchial challenge.
Lipworth BJ; Sims EJ; Das SK; Buck H; Paterson M
Ann Allergy Asthma Immunol; 2005 Jun; 94(6):675-81. PubMed ID: 15984601
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
